Dolca Thomas insider trades: Chinook Therapeutics (KDNY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dolca reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | KDNY | ↑ Buy | 10,000 | $21.22 | $212K | Direct | Sep 6, 2022 (4d) |
| Aug 18, 2020 | PRNB | ↓ Sell | 15,000 | $100.00 | $1.5M | Direct | Aug 20, 2020 (2d) |
| Jul 15, 2020 | PRNB | ↓ Sell | 15,000 | $80.07 | $1.2M | Direct | Jul 17, 2020 (2d) |
| Dec 19, 2019 | PRNB | ↓ Sell | 495 | $60.00 | $30K | Direct | Dec 20, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dolca Thomas's insider trades
Dolca Thomas is a director at Chinook Therapeutics (KDNY). Since Dec 19, 2019, Dolca has reported 1 open-market purchase worth $212K and 3 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares returned to the company (3 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KDNY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.